Mangal Credit And Fincorp Regulatory Approval

Mangal Credit And Fincorp Debt & Borrowing: ₹0.55 Cr

Mangal Credit paid ₹0.55 Crore of monthly interest on its secured NCDs, due 3 November 2026. No default or delay was reported.

Value

₹0.55 Cr

Mangal Credit And Fincorp Board Meeting Date

Mangal Credit and Fincorp has scheduled a board meeting on 3 November 2026 to consider unaudited standalone quarterly results for September 2026. No financial figures are disclosed yet.

Mangal Credit And Fincorp Debt & Borrowing: ₹0.48 Cr

Mangal Credit and Fincorp paid Rs 0.48 Crore monthly interest on its secured NCDs on October 23, 2026. The payment was made on time with no delay.

Value

₹0.48 Cr

Mangal Credit And Fincorp Convertible Warrants

Mangal Credit and Fincorp allotted 1,00,000 preferential warrants worth Rs. 2.47 Crore to Disha Jagdish Jain at Rs. 247 each. Post-allotment, her holding is 1,08,214 warrants.

Value

₹2.47 Cr

Mangal Credit And Fincorp Convertible Warrants

Mangal Credit and Fincorp allotted warrants worth ₹59.28 Crore at ₹247 each to five promoters. 25% subscription paid; post-allotment holdings computed on fully diluted basis.

Value

₹59.28 Cr

Mangal Credit And Fincorp Convertible Warrants

Mangal Credit and Fincorp allotted 25,00,000 convertible equity warrants at ₹247 per warrant to promoters and others, raising a total of ₹61.75 Crore.

Value

₹61.75 Cr

John Cockerill India Regulatory Approval

John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.

Gland Pharma Regulatory Approval

Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.

City Union Bank Regulatory Approval

City Union Bank disclosed RBI approval for appointing Shri Sankaran G as Executive Director (Whole-time Director) for three years. The board appointment and formal disclosures will follow later.

Execution

Three years from the date of taking charge

Lupin Regulatory Approval

Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.

Som Distilleries & Breweries Regulatory Approval

Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.

AGI Infra Regulatory Approval

Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.

Execution

Valid up to March 30, 2031